NCI SEER public-use data: applications and limitations in oncology research.

The Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute (NCI) collects cancer survival and incidence information from population-based cancer registries, encompassing 26% of the US population.[1]

[1]  E. Jensen,et al.  A Critical Analysis of the Surgical Management of Early-Stage Gallbladder Cancer in the United States , 2009, Journal of Gastrointestinal Surgery.

[2]  F. Saad,et al.  A Simple and Accurate Model for Prediction of Cancer-Specific Mortality in Patients Treated with Surgery for Primary Penile Squamous Cell Carcinoma , 2009, Clinical Cancer Research.

[3]  J. Plastaras,et al.  Adjuvant radiotherapy for pancreatic cancer is associated with a survival benefit primarily in stage IIB patients , 2009, Journal of Gastroenterology.

[4]  V. Cokkinides,et al.  Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors , 2008, Cancer.

[5]  T. Morgan,et al.  Primary scrotal cancer: disease characteristics and increasing incidence. , 2008, Urology.

[6]  J. Tward,et al.  Surgery and Radiotherapy Improves Survival in Patients With Anaplastic Thyroid Carcinoma: Analysis of the Surveillance, Epidemiology, and End Results 1983–2002 , 2008, American journal of clinical oncology.

[7]  A. Goel,et al.  Survival following primary androgen deprivation therapy among men with localized prostate cancer , 2008, Indian journal of urology : IJU : journal of the Urological Society of India.

[8]  D. Zelterman,et al.  Impact of immediate postoperative death on the estimation of a survival benefit from postoperative radiation therapy for cancer of the gallbladder. , 2008, Journal of Clinical Oncology.

[9]  Kara Hamilton,et al.  Second primary cancer after radiotherapy for prostate cancer--a seer analysis of brachytherapy versus external beam radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[10]  W. Nealon,et al.  672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma. , 2008, Surgery.

[11]  L. Wilson,et al.  Postmastectomy radiation therapy for lymph node‐negative, locally advanced breast cancer after modified radical mastectomy , 2008, Cancer.

[12]  Manal M. Hassan,et al.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Zhigang Duan,et al.  Limits of observational data in determining outcomes from cancer therapy , 2008, Cancer.

[14]  F. Hamdy,et al.  Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study. , 2008, The Lancet. Oncology.

[15]  B. Kavanagh,et al.  Use of external beam radiotherapy is associated with reduced incidence of second primary head and neck cancer: a SEER database analysis. , 2008, International journal of radiation oncology, biology, physics.

[16]  Dean F Sittig,et al.  Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Guo-Pei Yu,et al.  Five-year survival rates and time trends of laryngeal cancer in the US population. , 2008, Archives of otolaryngology--head & neck surgery.

[18]  L. Koniaris,et al.  Gender- and race-specific comparison of tobacco-associated cancer incidence trends in Florida with SEER regional cancer incidence data , 2008, Cancer Causes & Control.

[19]  B. Kavanagh,et al.  High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trials. , 2008, Clinical lung cancer.

[20]  J. Chan,et al.  Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas , 2008, Cancer.

[21]  Alex Kiss,et al.  Stage-Specific Effect of Adjuvant Therapy Following Gastric Cancer Resection: a Population-based Analysis of 4,041 Patients , 2008, Annals of Surgical Oncology.

[22]  J. Ross,et al.  Trends in childhood cancer incidence in the U.S. (1992–2004) , 2008, Cancer.

[23]  Bingshu E. Chen,et al.  Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. , 2007, Journal of the National Cancer Institute.

[24]  L. Wilson,et al.  Regarding adjuvant radiation therapy in merkel cell carcinoma: selection bias and its affect on overall survival. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  L. Wilson,et al.  The cutaneous B-cell lymphoma prognostic index: a novel prognostic index derived from a population-based registry. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  R. A. Robinson,et al.  Lung cancer histologic type in the surveillance, epidemiology, and end results registry versus independent review. , 2004, Journal of the National Cancer Institute.

[27]  G. Hortobagyi,et al.  Breast carcinoma in men , 2004, Cancer.

[28]  E. Holly,et al.  Expert Review of Non-Hodgkin’s Lymphomas in a Population-Based Cancer Registry , 2004, Cancer Epidemiology Biomarkers & Prevention.

[29]  C. Klabunde,et al.  Assessing Comorbidity Using Claims Data: An Overview , 2002, Medical care.

[30]  Kathleen Lang,et al.  Identifying Cancer Relapse Using SEER-Medicare Data , 2002, Medical care.

[31]  C. Klabunde,et al.  Linking Physician Characteristics and Medicare Claims Data: Issues in Data Availability, Quality, and Measurement , 2002, Medical care.

[32]  Ruth Etzioni,et al.  Estimating Health Care Costs Related to Cancer Treatment From SEER-Medicare Data , 2002, Medical care.

[33]  Beth A Virnig,et al.  Measuring Breast, Colorectal, and Prostate Cancer Screening With Medicare Claims Data , 2002, Medical care.

[34]  E. Guadagnoli,et al.  Patient Demographic and Socioeconomic Characteristics in the SEER-Medicare Database: Applications and Limitations , 2002, Medical care.

[35]  Colin B Begg,et al.  Measuring Complications of Cancer Treatment Using the SEER-Medicare Data , 2002, Medical care.

[36]  Beth A Virnig,et al.  Utility of the SEER-Medicare Data to Identify Chemotherapy Use , 2002, Medical care.

[37]  Deborah Schrag,et al.  Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population , 2002, Medical care.

[38]  Gregory S. Cooper,et al.  Studying Radiation Therapy Using SEER-Medicare-Linked Data , 2002, Medical care.

[39]  Marilyn M. Schapira,et al.  Methodological Issues in the Use of Administrative Claims Data to Study Surveillance After Cancer Treatment , 2002, Medical care.

[40]  G. Cooper,et al.  Use of SEER-Medicare Data for Measuring Cancer Surgery , 2002, Medical care.

[41]  Katherine L Kahn,et al.  Validity of cancer registry data for measuring the quality of breast cancer care. , 2002, Journal of the National Cancer Institute.

[42]  S. Glaser,et al.  Expert review of the diagnosis and histologic classification of Hodgkin disease in a population‐based cancer registry , 2001, Cancer.

[43]  B. Hankey,et al.  The surveillance, epidemiology, and end results program: a national resource. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[44]  Donald Rubin,et al.  Estimating Causal Effects from Large Data Sets Using Propensity Scores , 1997, Annals of Internal Medicine.

[45]  Joshua D. Angrist,et al.  Identification of Causal Effects Using Instrumental Variables , 1993 .

[46]  T. Eberlein.  Overall Survival and Cause-Specific Mortality of Patients With Stage T1a,bN0M0 Breast Carcinoma , 2009 .

[47]  E. Glatstein.  Adjuvant Radiation Therapy Is Associated With Improved Survival in Merkel Cell Carcinoma of the Skin , 2008 .